{
  "id": "6415ca99690f196b51000019",
  "type": "yesno",
  "question": "Have chimeric antigen receptor (CAR)-T cell therapies been approved for the treatment of B cell malignancies?",
  "ideal_answer": "Yes, four chimeric antigen receptor (CAR)-T cell therapies now approved for the treatment of B cell malignancies.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/33833444"
  ],
  "snippets": [
    {
      "text": "Engineered T cells have achieved success in the treatment of blood cancers, with four chimeric antigen receptor (CAR)-T cell therapies now approved for the treatment of B cell malignancies based on their unprecedented efficacy in clinical trials. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33833444",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}